Sign In
Buy LLY
$1,231.58
+45.87 (+3.87%)
At Close: Aug 10, 2026
6 Stocks Moved By Traders On 'Fast Money Halftime Report'
06:00pm, Thursday, 09'th Jun 2022 Benzinga
CNBC’s "Fast Money Halftime Report" delivers market-moving news to investors.
The commentary delivered by hosts of the show often moves the stocks mentioned. The information is collected and refine
Rigel (RIGL) wAIHA Study Fails to Meet Goals, Stock Tanks
04:48pm, Thursday, 09'th Jun 2022 Zacks Investment Research
Rigel (RIGL) phase III study evaluating fostamatinib in patients with warm autoimmune hemolytic anemia did not demonstrate statistical significance in the primary efficacy endpoint.
Final Trades: ChargePoint, Eli Lilly, Sabra Health Care & more
01:52pm, Thursday, 09'th Jun 2022
The "Halftime Report" traders give their top picks to watch for the second half.
Eli Lilly (LLY) Gains As Market Dips: What You Should Know
09:50pm, Wednesday, 08'th Jun 2022 Zacks Investment Research
Eli Lilly (LLY) closed at $313.49 in the latest trading session, marking a +0.45% move from the prior day.
Biopharmaceutical Stocks: The Bottoming Process Is Playing Out
02:30pm, Wednesday, 08'th Jun 2022
Three weeks ago, I suggested that the severe correction in biopharmaceutical stocks had ended. I expect the bottoming process to be choppy with a bias to the upside. The antecedent cause of the declin
Lilly (LLY) Eczema Candidate Keeps Skin Clearance for One Year
07:25pm, Tuesday, 07'th Jun 2022 Zacks Investment Research
Data from late-stage studies conducted by Eli Lilly (LLY) shows that its atopic dermatitis drug maintained improvement in skin clearance and itch relief in 8 of 10 patients for a one-year treatment.
Lilly (LLY) Eczema Candidate Keeps Skin Clearance for One Year
04:33pm, Tuesday, 07'th Jun 2022
Data from late-stage studies conducted by Eli Lilly (LLY) shows that its atopic dermatitis drug maintained improvement in skin clearance and itch relief in 8 of 10 patients for a one-year treatment.
4 Top Dividend Stocks To Watch In The Stock Market Today
04:30pm, Tuesday, 07'th Jun 2022
Check these dividend stocks out for your watchlist right now.
Eli Lilly weight loss drug for type-2 diabetes approved by the FDA
04:12pm, Tuesday, 07'th Jun 2022
Yahoo Finance senior health reporter Anjalee Khemlani details Eli Lilly's type-2 diabetes drug approval by the FDA for use as a weight loss drug.
Eli Lilly and Company (NYSE:LLY ) 82nd Scientific Sessions of the American Diabetes Association conference June 7, 2022 11:30 AM ET Company Participants Lauren Zierke - Senior Director of Investor Rel
Company News for Jun 7, 2022
01:36pm, Tuesday, 07'th Jun 2022 Zacks Investment Research
Companies in The News Are: SIAC,LLY,SEDG,SAVE,JBLU
Whistleblower sues Eli Lilly over drug manufacturing problems
11:50am, Tuesday, 07'th Jun 2022
(Reuters) -A former human resources officer at Eli Lilly and Co sued the drugmaker on Monday, alleging she was terminated after pointing out poor manufacturing practices and data falsification involvi
3 Big Ideas From JP Morgan With Up to Nearly 80% Upside
11:10am, Monday, 06'th Jun 2022
Recent moves within the market have absolutely crushed equities to bear market status.
Dr. Scott Gottlieb on promising new cancer drug data: 'The future is here'
10:56am, Monday, 06'th Jun 2022
Dr. Scott Gottlieb, former FDA commissioner and CNBC contributor, joins CNBC's 'Squawk Box' to discuss the top drug trial data coming out of the American Society of Clinical Oncology conference in Ch
2 Top Stocks to Buy With $500
02:30pm, Sunday, 05'th Jun 2022 The Motley Fool
These businesses are built to last.
